Insider · CIK 0001380185

El-Hibri Fuad

Reports to the SEC for 2 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001380185

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-12-03	EBSEmergent BioSolutions Inc.J Other	Director	JOther	+206K sh	—	—	206,434
2021-12-03	APVOAptevo Therapeutics Inc.J Other	Director	JOther	+108K sh	—	—	107,807
2021-12-03	APVOAptevo Therapeutics Inc.J Other	Director	JOther	+9,819 sh	—	—	9,819
2021-12-03	APVOAptevo Therapeutics Inc.J Other	Director	JOther	+7,373 sh	—	—	7,373
2021-12-03	EBSEmergent BioSolutions Inc.J Other	Director	JOther	+275K sh	—	—	274,930
2021-12-03	EBSEmergent BioSolutions Inc.J Other	Director	JOther	+3.02M sh	—	—	3,018,644
2021-06-01	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,678 sh	—	—	2,678
2021-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+893 sh	—	—	893
2021-02-24	EBSEmergent BioSolutions Inc. · Restricted Stock UnitA Award	Director	AAward	+13.9K sh	—	—	13,906
2021-02-24	EBSEmergent BioSolutions Inc. · Employee Stock Options (Right to Buy)A Award	Director	AAward	+27.8K sh	—	—	27,808
2020-11-10	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−19.4K sh	$88.21	−$1.71M	1,123,988
2020-11-10	EBSEmergent BioSolutions Inc.M Exercise/Conversion	Director	MExercise/Conversion	+19.4K sh	$26.45	+$513K	1,143,379
2020-11-10	EBSEmergent BioSolutions Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−19.4K sh	—	—	0
2020-11-09	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$95.26	−$1.91M	1,123,988
2020-11-09	EBSEmergent BioSolutions Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$26.45	+$529K	1,143,988
2020-11-09	EBSEmergent BioSolutions Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	19,391
2020-11-03	EBSEmergent BioSolutions Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	39,391
2020-11-03	EBSEmergent BioSolutions Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$26.45	+$529K	1,143,988
2020-11-03	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$90.74	−$1.81M	1,123,988
2020-11-02	EBSEmergent BioSolutions Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	59,391
2020-11-02	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$90.44	−$1.81M	1,123,988
2020-11-02	EBSEmergent BioSolutions Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$26.45	+$529K	1,143,988
2020-09-24	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−12.5K sh	$98.85	−$1.24M	1,123,988
2020-09-23	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−13K sh	$100.58	−$1.31M	1,136,523
2020-09-17	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$100.68	−$2.01M	1,149,523
2020-09-16	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$102.48	−$2.05M	1,169,523
2020-09-10	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$102.66	−$2.05M	1,189,523
2020-09-09	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$102.80	−$2.06M	1,209,523
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+170 sh	—	—	170
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,322 sh	—	—	1,322
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,785 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−892 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,339 sh	—	—	0
2020-07-02	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,571 sh	—	—	3,571
2020-04-30	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$74.01	−$1.48M	1,229,523
2020-04-29	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$74.24	−$1.48M	1,249,523
2020-04-23	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$68.49	−$1.37M	1,269,523
2020-04-22	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$66.81	−$1.34M	1,289,523
2020-04-16	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−20K sh	$62.47	−$1.25M	1,309,523
2020-04-15	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−12.5K sh	$62.58	−$785K	1,329,523
2020-04-14	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−6,261 sh	$62.99	−$394K	1,342,060
2020-04-13	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−17.1K sh	$62.25	−$1.06M	1,348,321
2020-04-09	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−23.7K sh	$61.83	−$1.47M	1,365,392
2020-04-08	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−13K sh	$60.75	−$790K	1,413,470
2020-04-08	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−24.4K sh	$61.34	−$1.49M	1,389,108
2020-04-07	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−14.3K sh	$60.76	−$871K	1,426,470
2020-04-06	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−28.2K sh	$60.50	−$1.71M	1,440,806
2020-02-27	EBSEmergent BioSolutions Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,794 sh	—	—	1,482,737
2020-02-27	EBSEmergent BioSolutions Inc.F Tax Payment	Director	FTax Payment	−3,854 sh	$58.42	−$225K	1,478,883
2020-02-27	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−9,837 sh	$56.97	−$560K	1,469,046

Recent filings

Accepted (ET)
Dec 74
El-Hibri Fuad0000899243-21-047222
SEC(opens sec.gov)
Dec 74
El-Hibri Fuad0001019056-21-000634
SEC(opens sec.gov)
Jun 24
El-Hibri Fuad0001019056-21-000355
SEC(opens sec.gov)
Feb 264
El-Hibri Fuad0000899243-21-008483
SEC(opens sec.gov)
Feb 174
El-Hibri Fuad0001019056-21-000140
SEC(opens sec.gov)
Nov 124
El-Hibri Fuad0000899243-20-030866
SEC(opens sec.gov)
Nov 44
El-Hibri Fuad0000899243-20-030431
SEC(opens sec.gov)

Companies

Address

2273 RESEARCH BLVD, SUITE 400

ROCKVILLE, MD, 20850